Zealand Pharma

Description

Zealand Pharma is a biotechnology company focused on advancing medicines for metabolic health, including obesity, inflammation, and rare diseases such as short bowel syndrome. By combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data driven and AI/ML approaches, Zealand Pharma aims to lead a new era in metabolic health. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Massachusetts. Learn more at www.zealandpharma.com.